Cargando…
Development of Peptidomimetics Targeting IAPs
Inhibitor of apoptosis proteins (IAPs) such as XIAP subvert apoptosis by binding and inhibiting caspases. Because occupation of the XIAP BIR3 peptide binding pocket by Smac abolishes the XIAP–caspase 9 interaction, it is a proapoptotic event of great therapeutic interest. An assay for pocket binding...
Autores principales: | Sharma, Sushil K., Straub, Christopher, Zawel, Leigh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Kluwer Academic Publishers
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710984/ https://www.ncbi.nlm.nih.gov/pubmed/19617919 http://dx.doi.org/10.1007/s10989-005-9003-2 |
Ejemplares similares
-
IAP inhibitors enhance co-stimulation to promote tumor immunity
por: Dougan, Michael, et al.
Publicado: (2010) -
The non‐peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis
por: Knoll, Gertrud, et al.
Publicado: (2021) -
Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022) -
IAP proteins as targets for drug development in oncology
por: Dubrez, Laurence, et al.
Publicado: (2013) -
P3Ka: A Driver of Tumor Metastasis?
por: Zawel, Leigh
Publicado: (2010)